Abstract:<h3 class="Heading">Summary</h3><p class="Para">Sarcopenia was reported to be significantly associated with osteoporosis. In this study, we reported for the first time that sarcopenia was an independent risk predictor of osteoporotic vertebral compression refractures (OVCRFs). Other risk factors of OVCRFs are low bone mass density T-scores, female sex, and advanced age.</p><h3 class="Heading">Introduction</h3><p class="Para">The purpose of this study was to investigate the association between osteoporotic vertebral compression refractures (OVCRFs) and sarcopenia, and to identify other risk factors of OVCRFs.</p><h3 class="Heading">Methods</h3><p class="Para">We evaluated 237 patients with osteoporotic vertebral compression fracture who underwent percutaneous kyphoplasty (PKP) in our hospital from August 2016 to December 2017. To diagnose sarcopenia, a cross-sectional computed tomography (CT) image at the inferior aspect of the third lumbar vertebra (L3) was selected for estimating muscle mass. Grip strength was used to assess muscle strength. Possible risk factors, such as age, sex, body mass index (BMI), bone mineral density (BMD), location of the treated vertebra, anterior-posterior ratio (AP ratio) of the fractured vertebra, cement leakage, and vacuum clefts, were assessed. The multivariable analysis was used to determine the risk factors of OVCRFs.</p><h3 class="Heading">Results</h3><p class="Para">During the follow-up period, OVCRFs occurred in 64 (27.0%) patients. Sarcopenia was present in 48 patients (20.3%), including 21 OVCRFs and 27 non-OVCRFs patients. Sarcopenia was significantly correlated with advanced age, lower BMI, lower BMD, and hypoalbuminemia. Compared with non-sarcopenic patients, sarcopenic patients had higher OVCRFs risk. In univariate analysis, sarcopenia (<em class="EmphasisTypeItalic">p</em> = 0.003), female (<em class="EmphasisTypeItalic">p</em> = 0.024), advanced age (≥ 75 years; <em class="EmphasisTypeItalic">p</em> < 0.001), lower BMD (<em class="EmphasisTypeItalic">p</em> < 0.001), lower BMI (<em class="EmphasisTypeItalic">p</em> = 0.01), TL junction (vertebral levels at the thoracolumbar junction) (<em class="EmphasisTypeItalic">p</em> = 0.01), cardiopulmonary comorbidity (<em class="EmphasisTypeItalic">p</em> = 0.042), and hypoalbuminemia (<em class="EmphasisTypeItalic">p</em> = 0.003) were associated with OVCRFs. Multivariable analysis revealed that sarcopenia (OR 2.271; 95% CI 1.069–4.824, <em class="EmphasisTypeItalic">p</em> = 0.033), lower BMD (OR 1.968; 95% CI 1.350–2.868, <em class="EmphasisTypeItalic">p</em> < 0.001), advanced age (≥ 75 years; OR 2.431; 95% CI 1.246–4.744, <em class="EmphasisTypeItalic">p</em> = 0.009), and female sex (OR 4.666; 95% CI 1.400–15.552, <em class="EmphasisTypeItalic">p</em> = 0.012) were independent risk predictors of OVCRFs.</p><h3 class="Heading">Conclusions</h3><p class="Para">Sarcopenia is an independent risk predictor of osteoporotic vertebral compression refractures. Other factors affecting OVCRFs are low BMD T-scores, female sex, and advanced age.</p>

Evaluation of Sarcopenia by Psoas Muscle Measurements in Osteoporotic Patients with Vertebral Compression Fracture

Radiographic Thigh Muscle Measurements Are a Reliable Predictor of Psoas Area and Sarcopenia

Correlation of Psoas Muscle Index with Fragility Vertebral Fracture: A Retrospective Cross-Sectional Study of Middle-Aged and Elderly Women

Is decreased psoas volume a risk factor for hip fracture? A comparative study of patients with and without hip fractures using the exact matching technique

Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia

Psoas muscle area is associated with prognosis in elderly patients with hip fracture

The role of sarcopenia in fragility fractures of the pelvis - is sarcopenia an underestimated risk factor?

Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology

Ultrasonographically Measured Rectus Femoris Cross-sectional Area might Predict Osteosarcopenia

Computed tomography measured epicardial adipose tissue and psoas muscle attenuation: new biomarkers to predict major adverse cardiac events and mortality in patients with heart disease and critically ill patients. Part II: Psoas muscle area and density

Psoas Muscle Index and Density as Prognostic Predictors in Patients Hospitalized with Acute Pancreatitis

Low muscle mass determined by psoas muscle area does not correlate with dual-energy x-ray absorptiometry or total lumbar muscle mass scores: A prospective cohort study of patients undergoing vascular surgery

Sarcopenia and osteoporosis in patients with psoriatic arthritis: A single-center retrospective study

The Impact of Sarcopenia on the Clinical Outcomes of Percutaneous Kyphoplasty in Patients With Osteoporotic Vertebral Compression Fracture: A Retrospective Cohort Study

Sarcopenia: An Assessment into the Prevalence and Disease Burden in Chronic Pancreatitis Patients

Psoas muscle cross sectional area relates to bone density and microarchitecture in candidates for spine fusion surgery

The association between sarcopenia and osteoporotic vertebral compression refractures

Prevalence of Sarcopenia Determined by Computed Tomography in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Observational Studies

Assessment of Psoas Muscle Index in Middle-Aged Type 2 Diabetes Patients: Impact of Insulin Therapy on Sarcopenia

CT-based sarcopenia assessment: Predicting outcomes in acute infection patients